Rigas farmaceitiska fabrika AS: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Rigas Farmaceitiska Fabrika AS Appoints SIA ABrevizija as Auditor
Rigas Farmaceitiska Fabrika AS announced that it has decided, at its Extraordinary Shareholder's Meeting, to appoint SIA ABrevizija as the Company’s auditor for the financial year 2012.
Latest Developments for Rigas farmaceitiska fabrika AS
- Rigas Farmaceitiska Fabrika AS announces further information concerning mandatory takeover bid by Capital Holding SIA
- Capital Holding SIA announces mandatory takeover bid of Rigas Farmaceitiska Fabrika AS shares
- Capital Holding SIA increases its stake in Rigas Farmaceitiska Fabrika AS
- Rigas Farmaceitiska Fabrika AS issues FY 2014 net turnover and net profit guidance, appoints external auditors for FY 2014
Latest Key Developments in Pharmaceuticals
- Supreme Pharmaceuticals Inc appoints new President
- AstraZeneca Plc's LYNPARZA approved by the US FDA
- Roche Holding AG acquires Bina Technologies and enters genomic informatics market
- Teva Pharmaceutical Industries Ltd announces FDA approval of QNASL Nasal Aerosol for treatment of children with seasonal and Perennial Allergic Rhinitis
- Share this
- Digg this